Commercial Opportunities: Vaccine Development

Formaldehyde-free toxoids Full Details>>

Scientists at the Defence Science and Technology Laboratory (Dstl) in the UK have developed a method to treat a toxin to produce a toxoid for use in vaccines that does not involve the use of formaldehyde. These toxoids are more stable, quicker to produce and avoid the toxicity associated with formaldehyde.

Single dose mucosal vaccines Full Details>>

This new method of encapsulating biological molecules allows their use as effective mucosal vaccines in just a single dose. The vaccines are delivered to the mucosal surfaces in a way that stimulates the immune response required for a protective effect, and can be combined with immunostimulatory substances for an enhanced response.